세계의 질량 분석 시장 보고서(2025년)
Mass Spectrometry Global Market Report 2025
상품코드 : 1824292
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 질량 분석 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년 연평균 복합 성장률(CAGR)은 10.2%로 확대되어 106억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 헬스케어 지출 증가, 식품안전 용도 확대, 신흥 시장에서의 채용, 정밀의료의 진보, 타 업종 콜라보레이션에 기인하고 있습니다. 예측기간의 주요 동향으로는 이온화 기술 진보, 식음료 검사에서 역할 확대, 멀티오믹스 연구를 위한 협업, 데이터 접근성 향상, 클라우드 기반 솔루션 등이 있습니다.

향후 5년간의 성장률 10.2%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 독일과 일본에서 수입되는 고분해능 질량 분석기와 이온화 모듈의 비용을 상승시켜 미국의 의료 공급 체인을 혼란시켜 검사 진단 지연과 병리 부문 운영 비용 상승을 초래할 수 있습니다. 또한 상호관세와 무역마찰, 무역제한의 격화에 의한 세계경제나 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 예측됩니다.

예상되는 만성 질환 증가는 향후 질량 분석 시장의 성장을 견인합니다. 만성 질환은 3개월 이상 지속되어 시간이 지남에 따라 악화되는 것으로 세계적으로 유행하고 있습니다. 질량 분석기술은 만성질환과 관련된 바이오마커 및 대사산물의 확인, 정량, 분석에 중요한 역할을 합니다. 세계보건기구(WHO)에 따르면, 비감염성 질환(NCDs) 또는 만성질환은 세계 연간 사망자 수 4,100만 명의 74%를 차지하고 있습니다. 심혈관 질환, 암, 만성 호흡기 질환, 당뇨병의 유병률 증가는 질병 분석에서 질량 분석의 중요성을 강조합니다. 게다가 미국 국립보건실(NIH)의 보고는 적어도 하나의 만성질환을 가진 50세 이상의 인구가 2020년 7,152만 2,000명에서 2050년에는 1억 4,266만명으로 99.5% 증가할 것으로 예측했습니다. 따라서 질량 분석 시장은 만성 질환의 유병률이 증가함에 따라 성장을 목격하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Mass spectrometry is an analytical technique utilized for the identification and quantification of molecules based on their mass-to-charge ratio. The process involves ionizing a sample, separating the resulting ions according to their mass-to-charge ratio, and then detecting them to generate a mass spectrum.

The main technologies employed in mass spectrometry include hybrid mass spectrometry, single mass spectrometry, and inductively coupled plasma mass spectrometry (ICP-MS). Hybrid mass spectrometry combines multiple mass spectrometry techniques to enhance analytical capabilities and improve molecular characterization. This technology finds applications in various fields, including life science research, drug discovery, environmental testing, food testing, applied industries, and clinical diagnostics. Industries and sectors utilizing mass spectrometry include the pharmaceutical and biotechnology industries, research and academic institutes, environmental testing industry, food and beverage testing industry, petrochemical industry, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The mass spectrometry market research report is one of a series of new reports from The Business Research Company that provides mass spectrometry market statistics, including the mass spectrometry industry global market size, regional shares, competitors with a mass spectrometry market share, detailed mass spectrometry market segments, market trends, and opportunities, and any further data you may need to thrive in the mass spectrometry industry. This mass spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mass spectrometry market size has grown strongly in recent years. It will grow from $6.65 billion in 2024 to $7.2 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to regulatory compliance, increased research and development investments, increased pharmaceutical and biotechnology demand, environmental monitoring, clinical diagnostics have shaped historical growth.

The mass spectrometry market size is expected to see rapid growth in the next few years. It will grow to $10.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing healthcare expenditure, expanding applications in food safety, emerging markets adoption, advancements in precision medicine, cross-industry collaborations. Major trends in the forecast period include advances in ionization techniques, growing role in food and beverage testing, collaboration for multi-omics research, enhanced data accessibility and cloud-based solutions.

The forecast of 10.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical supply chains by increasing costs for high-resolution mass spectrometers and ionization modules imported from Germany and Japan, potentially delaying lab diagnostics and raising pathology department operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in chronic diseases is set to drive the growth of the mass spectrometry market in the future. Chronic diseases, lasting for three months or longer and worsening over time, are prevalent globally. Mass spectrometry techniques play a crucial role in identifying, quantifying, and analyzing biomarkers and metabolites associated with chronic diseases. According to the World Health Organization, non-communicable diseases (NCDs) or chronic diseases account for 74% of the 41 million annual deaths worldwide. The increasing prevalence of cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes underscores the importance of mass spectrometry in disease analysis. Furthermore, a report from the National Institutes of Health (NIH) predicts a 99.5% increase in the number of people aged 50 and older with at least one chronic illness, from 71.522 million in 2020 to 142.66 million in 2050. Hence, the mass spectrometry market is witnessing growth due to the escalating prevalence of chronic diseases.

The expansion of the beverage industry is expected to contribute to the growth of the mass spectrometry market. The beverage industry involves the production, distribution, and sale of liquid refreshments. Mass spectrometry is employed for precise analysis and characterization of compounds, ensuring quality control, flavor profiling, and identification of contaminants in beverages. In the United States, the beverage industry is valued at $146 billion and is projected to experience an annual growth rate of 1.7% by 2027, according to BlueCart. Therefore, the growing beverage industry is a driving factor for the mass spectrometry market.

Product innovation stands out as a prominent trend in the mass spectrometry market. Leading companies in the market are dedicated to developing innovative products with advanced features to fortify their market positions. For example, Agilent Technologies Inc., a U.S.-based company, launched LC/MS and GC/MS quadrupole mass spectrometers in June 2022. The Agilent 6475 triple quadrupole LC/MS system is characterized by sensitivity, robustness, and ruggedness. Major features include a unique superheated Agilent Jet Stream (AJS) ion source, curved and tapered collision cell, +- 20 kV high-energy dynode detector system, and heated hyperbolic quadrupoles. Additionally, the system offers early maintenance feedback, intelligent secondary injection workflows, and scheduled tune and check-tune.

Major companies in the mass spectrometry market are prioritizing the development of advanced mass spectrometers to gain a competitive edge. The Astral analyzer, a state-of-the-art mass spectrometer known for its fast throughput, high sensitivity, and deep proteome coverage, is one such example. Thermo Fisher, a U.S.-based supplier of analytical instruments, launched the Orbitrap Astral mass spectrometer in June 2023. This groundbreaking technology allows researchers to efficiently discover previously undetected proteins, aiding in the identification of new clinical biomarkers and early disease detection. The Orbitrap Astral builds on Thermo Fisher's Orbitrap mass spectrometry platform, providing up to two times deeper proteome coverage and up to four times more throughput than current spectrometers.

In July 2022, Inotiv Inc., a U.S.-based medical research organization specializing in non-clinical and analytical methods for drug discovery and development, acquired Protypia, Inc. for an undisclosed amount. This strategic acquisition enhances Inotiv's bioanalytical capabilities and allows prospective consumers to translate clinical findings back into their discovery and preclinical pipelines. Protypia Inc., a U.S.-based proteomics bioanalytical company, operates in the mass spectrometry market.

Major companies operating in the mass spectrometry market include Agilent Technologies Inc., Bruker Corporation, JEOL Ltd., LECO Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, AB Sciex Pte Ltd., Danaher Corporation, Hitachi Ltd., Rigaku Corporation, Advion Inc., AMETEK. Inc., Analytik Jena GmbH, DANI Instruments S.p.A., Eurofins Scientific SE, FLIR Systems Inc., MKS Instruments, Elementar Analysensysteme GmbH, Hiden Analytical Europe GmbH, SPECTRO Analytical Instruments GmbH, EXUM INSTRUMENTS INC., 908 Devices Inc., MassTech Inc., Newomics Inc., Microsaic Systems plc, SCIEX AB, Kore Technologies Ltd., IonSense Inc.

North America was the largest region in the mass spectrometry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the mass spectrometry market size forecast period. The regions covered in the mass spectrometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the mass spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The mass spectrometry market consists of revenues earned by entities by providing services such as analytical testing, proteomics analysis, metabolomics studies, drug discovery support, environmental analysis, and forensic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The mass spectrometry market also includes sales of mass spectrometers, ionization sources, and detectors, which are used in providing mass spectrometry services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mass Spectrometry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mass spectrometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for mass spectrometry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mass spectrometry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Mass Spectrometry Market Characteristics

3. Mass Spectrometry Market Trends And Strategies

4. Mass Spectrometry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mass Spectrometry Growth Analysis And Strategic Analysis Framework

6. Mass Spectrometry Market Segmentation

7. Mass Spectrometry Market Regional And Country Analysis

8. Asia-Pacific Mass Spectrometry Market

9. China Mass Spectrometry Market

10. India Mass Spectrometry Market

11. Japan Mass Spectrometry Market

12. Australia Mass Spectrometry Market

13. Indonesia Mass Spectrometry Market

14. South Korea Mass Spectrometry Market

15. Western Europe Mass Spectrometry Market

16. UK Mass Spectrometry Market

17. Germany Mass Spectrometry Market

18. France Mass Spectrometry Market

19. Italy Mass Spectrometry Market

20. Spain Mass Spectrometry Market

21. Eastern Europe Mass Spectrometry Market

22. Russia Mass Spectrometry Market

23. North America Mass Spectrometry Market

24. USA Mass Spectrometry Market

25. Canada Mass Spectrometry Market

26. South America Mass Spectrometry Market

27. Brazil Mass Spectrometry Market

28. Middle East Mass Spectrometry Market

29. Africa Mass Spectrometry Market

30. Mass Spectrometry Market Competitive Landscape And Company Profiles

31. Mass Spectrometry Market Other Major And Innovative Companies

32. Global Mass Spectrometry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mass Spectrometry Market

34. Recent Developments In The Mass Spectrometry Market

35. Mass Spectrometry Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기